Developmental biology meets toxicology: contributing reproductive mechanisms to build adverse outcome pathways

Monica Kam Draskau1, Cassy M Spiller2, Julie Boberg1

  • 1Division of Diet, Disease Prevention and Toxicology, National Food Institute, Technical University of Denmark, Kongens Lyngby, Denmark.

Insights

The adverse outcome pathway (AOP) framework leverages bioscience research to create new testing strategies for chemical safety. This approach aims to reduce animal testing and improve the identification of chemicals harmful to human reproductive health.

Area of Science:

  • Toxicology
  • Developmental Biology
  • Reproductive Biology

Background:

  • Adverse Outcome Pathways (AOPs) describe mechanistic sequences from chemical triggers to toxicological effects.
  • The AOP framework facilitates collaboration between researchers and regulatory bodies.
  • Fundamental bioscience knowledge underpins AOP development.

Purpose of the Study:

  • To inform bioscientific professionals about the AOP framework.
  • To encourage interdisciplinary collaborations for applied toxicology.
  • To promote the development of novel chemical testing strategies.

Main Methods:

  • Review of the AOP framework and its application in biosciences.
  • Discussion on harnessing fundamental biological knowledge for regulatory toxicology.
  • Focus on mechanistic understanding for alternative testing methods.

Main Results:

  • AOPs provide a platform for integrating basic research with regulatory needs.
  • Knowledge-based approaches can lead to reduced reliance on animal testing.
  • The framework supports the development of in vitro and in silico testing methods.

Conclusions:

  • Fundamental bioscience research is crucial for advancing AOPs.
  • AOPs can enhance understanding of chemical impacts on reproductive health.
  • Cross-disciplinary collaboration is key to efficient chemical screening and risk assessment.

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
3.9K
Toxic Reactions: Overview01:26

Toxic Reactions: Overview

When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
1.7K
Types of Toxins01:36

Types of Toxins

Humans continually engage with an environment rich in potentially harmful chemicals. These are introduced to our bodies through inhalation, ingestion, or skin contact. These chemicals exist in various forms, such as air and environmental pollutants, agricultural chemicals, organic solvents, and heavy metals.
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
3.1K
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.8K
Effects of Chemicals: Overview01:27

Effects of Chemicals: Overview

Drugs, encompassing various chemical compounds from natural sources, lab synthesis, or genetic engineering, elicit different biological responses in living organisms. Some of these responses are desirable or therapeutic, while others are undesirable. The primary goal of administering a drug is to achieve a therapeutic effect, that is, to address a specific disease or health condition. Any concurrent effects outside of this therapeutic outcome are considered undesirable. These undesirable...
1.9K